Table: begin end state 1 16 cytoplasmic 17 38 transmembrane 39 57 non-cytoplasmic 58 77 transmembrane 78 85 cytoplasmic 86 105 transmembrane 106 110 non-cytoplasmic 111 133 transmembrane 134 143 cytoplasmic 144 162 transmembrane 163 173 non-cytoplasmic 174 193 transmembrane 194 253 cytoplasmic 254 276 transmembrane 277 289 non-cytoplasmic 290 312 transmembrane 313 319 cytoplasmic 320 341 transmembrane 342 352 non-cytoplasmic 353 374 transmembrane 375 386 cytoplasmic 387 412 transmembrane 413 418 non-cytoplasmic 419 437 transmembrane 438 463 cytoplasmic
Input: >N515DRAFT_1228 MNSQAIATPTAHVKGTVIYTCVLAALAGLMFGLDIGVISGASQFIKAEFAISDHTIEWIV SSMMFGAAVGALGAGWLSSHLGRKRSLILGAILFVIGSLLCGLAWSPETLIAARVILGLA IGIATFTAPLYLAEVAPEHIRGAMISTYQLMITIGILVAFLSDTALSYHGAWRWMLGVIA IPGALFLLGVLGLPDSPRWLMMRGRRDEAIDVLRRLRGDEVVVAREAADIEEQLKTPQRG WDLFAENPNFRRSVFLGALLQIMQQFTGMNVVMYYAPRIFQEMGYDTAAQMWFTALVGLT NVLATFIAIALIDRWGRKPILYTGFAVMAVGLGVVGALMNGGINGQTEQYTCVAMLLFFI VGFAMSAGPLVWTLCSEIQPLKGRDFGIGVSTFTNWITNMVVGFTFLSLLNTIGNASTFW LYAALNAVFIVLTFWLVPETKGVTLEQIERNLMAGKRLRDIGR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server